Stock Price Quote

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE1181.351.4 (+0.12 %)
PREV CLOSE ( ) 1179.95
OPEN PRICE ( ) 1179.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 46263
TODAY'S LOW / HIGH ( )1176.30 1186.00
52 WK LOW / HIGH ( )828.65 1267.5
NSE1181.201.75 (+0.15 %)
PREV CLOSE( ) 1179.45
OPEN PRICE ( ) 1179.45
BID PRICE (QTY) 1181.20 (357)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 828212
TODAY'S LOW / HIGH( ) 1176.05 1186.00
52 WK LOW / HIGH ( )828.4 1267.65
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 6640 2323

Email info@lupinworld.com/investorservices@lupin.com/info@lupin.com

Website www.lupinworld.com/www.lupin.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

14Jul Lupin, S Chand And Company and CEAT to
Lupin has launched Tavaborole Topical Solution, 5% having received an ap..
13Jul Lupin launches Tavaborole Topical Solu
Lupin has launched Tavaborole Topical Solution, 5% having received an ap..
13Jul Lupin informs about press release
Lupin has informed that it has enclosed a Press Release as regards launc..
02Jul Lupin’s arm gets USFDA’s nod for suppl
Lupin’s U.S. based wholly-owned subsidiary -- Lupin Pharmaceuticals, Inc..
02Jul Lupin gains as its arm gets USFDA’s no
Lupin is currently trading at Rs. 1155.15, up by 8.90 points or 0.78% fr..

Financials

in Millions
QTR Mar 21 ANNUAL 21
Net Profit3163.612586.2
Gross Profit 3538 16297
Operating Profit 4911.221731.5
Net Sales 25159.6110559.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  17809.30 (1.70%)
M.Cap ( in Cr)37843.52
NGL Fine-Chem (BSE)
peergroup  3099.75 (3.61%)
M.Cap ( in Cr)1915.03
Glaxosmithkline Phar (BSE)
peergroup  1681.70 (4.52%)
M.Cap ( in Cr)28489.01
Ajanta Pharma (BSE)
peergroup  2167.00 (2.57%)
M.Cap ( in Cr)18751.43
Solara Active Pharma (BSE)
peergroup  1708.20 (3.00%)
M.Cap ( in Cr)6137.52

Shareholding Pattern

PROMOTERS 46.84%
NON-INSTITUTION 12.47%
MUTUAL FUNDS/UTI 11.43%
FI/BANKS/INSURANCE 10.25%
GOVERNMENT 0.28%
FII 0%

About Lupin Ltd.

Lupin Ltd. was incorporated in the year 1983. Its today's share price is 1181.35. Its current market capitalisation stands at Rs 53628.97 Cr. In the latest quarter, company has reported Gross Sales of Rs. 118962.8 Cr and Total Income of Rs.111850.2 Cr. The company's management includes R V Satam, Mark D McDade, Punita Kumar Sinha, K B S Anand, Christine Mundkur, Jean-Luc Belingard, Ramesh Swaminathan, Nilesh Gupta, Kamal K Sharma, Manju D Gupta.

It is listed on the BSE with a BSE Code of 500257 , NSE with an NSE Symbol of LUPIN and ISIN of INE326A01037. It's Registered office is at Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East)Mumbai-400055, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arora & Arora, BSR & Co LLP, Deloitte Haskins & Sells, Deloitte Haskins & Sells LLP, Deloittee Haskins & Sells, SS Kapoor & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)